165 related articles for article (PubMed ID: 15200337)
1. Synthesis of 4-azido-4-deoxy-Neu5,7,8,9Ac42en1Me. A key intermediate for the synthesis of GG167 from D-glucono-delta-lactone.
Liu KG; Yan S; Wu YL; Yao ZJ
Org Lett; 2004 Jun; 6(13):2269-72. PubMed ID: 15200337
[TBL] [Abstract][Full Text] [Related]
2. The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid: a potent influenza virus sialidase inhibitor.
von Itzstein M; Wu WY; Jin B
Carbohydr Res; 1994 Jun; 259(2):301-5. PubMed ID: 8050102
[No Abstract] [Full Text] [Related]
3. Distinguishing mammalian sialidases by inhibition kinetics with novel derivatives of 5-acetamido-2,6-anhydro-3,5-dideoxy-D-glycero-D-galacto-non-2-enonic acid, an unsaturated derivative of N-acetylneuraminic acid.
Warner TG; Louie A; Potier M; Ribeiro A
Carbohydr Res; 1991 Aug; 215(2):315-21. PubMed ID: 1794129
[TBL] [Abstract][Full Text] [Related]
4. Determination of the novel sialic acid analog GG167 (GR121167X) in human urine by liquid chromatography: direct injection with column switching.
Morris DM; Hussey BK; Geurin SL; Selinger KA
J Pharm Biomed Anal; 1995 Dec; 14(1-2):191-201. PubMed ID: 8833982
[TBL] [Abstract][Full Text] [Related]
5. Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza.
Macdonald SJ; Cameron R; Demaine DA; Fenton RJ; Foster G; Gower D; Hamblin JN; Hamilton S; Hart GJ; Hill AP; Inglis GG; Jin B; Jones HT; McConnell DB; McKimm-Breschkin J; Mills G; Nguyen V; Owens IJ; Parry N; Shanahan SE; Smith D; Watson KG; Wu WY; Tucker SP
J Med Chem; 2005 Apr; 48(8):2964-71. PubMed ID: 15828835
[TBL] [Abstract][Full Text] [Related]
6. Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities.
Li J; Zheng M; Tang W; He PL; Zhu W; Li T; Zuo JP; Liu H; Jiang H
Bioorg Med Chem Lett; 2006 Oct; 16(19):5009-13. PubMed ID: 16876409
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K
N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.
Hayden FG; Treanor JJ; Betts RF; Lobo M; Esinhart JD; Hussey EK
JAMA; 1996 Jan 24-31; 275(4):295-9. PubMed ID: 8544269
[TBL] [Abstract][Full Text] [Related]
9. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.
Smith PW; Sollis SL; Howes PD; Cherry PC; Starkey ID; Cobley KN; Weston H; Scicinski J; Merritt A; Whittington A; Wyatt P; Taylor N; Green D; Bethell R; Madar S; Fenton RJ; Morley PJ; Pateman T; Beresford A
J Med Chem; 1998 Mar; 41(6):787-97. PubMed ID: 9526555
[TBL] [Abstract][Full Text] [Related]
10. Chemoselective synthesis of sialic acid 1,7-lactones.
Allevi P; Rota P; Scaringi R; Colombo R; Anastasia M
J Org Chem; 2010 Aug; 75(16):5542-8. PubMed ID: 20704429
[TBL] [Abstract][Full Text] [Related]
11. An azidoaryl thioglycoside of sialic acid. A potential photoaffinity probe of sialidases and sialic acid-binding proteins.
Warner TG; Lee LA
Carbohydr Res; 1988 May; 176(2):211-8. PubMed ID: 3416319
[TBL] [Abstract][Full Text] [Related]
12. New influenza drugs zanamivir (Relenza) and oseltamivir (Tamiflu): unexpected serious reactions.
Macdonald L
CMAJ; 2000 Oct; 163(7):879-81, 883-5. PubMed ID: 11033723
[No Abstract] [Full Text] [Related]
13. Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.
Matsumoto K; Ogawa N; Nerome K; Numazaki Y; Kawakami Y; Shirato K; Arakawa M; Kudoh S; Shimokata K; Nakajima S; Yamakido M; Kashiwagi S; Nagatake T
Antivir Ther; 1999; 4(2):61-8. PubMed ID: 10682150
[TBL] [Abstract][Full Text] [Related]
14. 2,3-Dehydro-4-epi-N-acetylneuraminic acid; a neuraminidase inhibitor.
Kumar V; Kessler J; Scott ME; Patwardhan BH; Tanenbaum SW; Flashner M
Carbohydr Res; 1981 Aug; 94(2):123-30. PubMed ID: 7273035
[TBL] [Abstract][Full Text] [Related]
15. Treating influenza with zanamivir.
Read RC
Lancet; 1998 Dec; 352(9144):1872-3. PubMed ID: 9863779
[No Abstract] [Full Text] [Related]
16. Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
Watson KG; Cameron R; Fenton RJ; Gower D; Hamilton S; Jin B; Krippner GY; Luttick A; McConnell D; MacDonald SJ; Mason AM; Nguyen V; Tucker SP; Wu WY
Bioorg Med Chem Lett; 2004 Mar; 14(6):1589-92. PubMed ID: 15006410
[TBL] [Abstract][Full Text] [Related]
17. [symbol: see text] Zanamivir for influenza.
Drug Ther Bull; 1999 Nov; 37(11):81-4. PubMed ID: 10696691
[TBL] [Abstract][Full Text] [Related]
18. [Neuraminidase inhibitors against influenza].
Med Monatsschr Pharm; 1999 Sep; 22(9):262-4. PubMed ID: 10536414
[No Abstract] [Full Text] [Related]
19. Automated high-performance liquid chromatographic method for the determination of a neuraminidase inhibitor (GG167) in human serum by pre-column fluorescence derivatisation using benzoin.
Stubbs RJ; Harker AJ
J Chromatogr B Biomed Appl; 1995 Aug; 670(2):279-85. PubMed ID: 8548018
[TBL] [Abstract][Full Text] [Related]
20. Neuraminidase inhibitors and relief of influenza symptoms.
Lemon M; Meade F
S D J Med; 2000 Mar; 53(3):99-100. PubMed ID: 10745653
[No Abstract] [Full Text] [Related]
[Next] [New Search]
